IPCA LABORATORIES
Back to Balance Sheet
|
IPCA LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹2,356 Cr | ₹1,806 Cr | ₹1,466 Cr | ₹1,161 Cr | ₹1,326 Cr |
What is the latest Total Current Liabilities ratio of IPCA LABORATORIES ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹2,356 Cr |
Mar2023 | ₹1,806 Cr |
Mar2022 | ₹1,466 Cr |
Mar2021 | ₹1,161 Cr |
Mar2020 | ₹1,326 Cr |
How is Total Current Liabilities of IPCA LABORATORIES Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹2,356 Cr | 30.45 | |
Mar2023 | ₹1,806 Cr | 23.19 | |
Mar2022 | ₹1,466 Cr | 26.31 | |
Mar2021 | ₹1,161 Cr | -12.51 | |
Mar2020 | ₹1,326 Cr | - |
Compare Total Current Liabilities of peers of IPCA LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
IPCA LABORATORIES | ₹35,184.4 Cr | -2.6% | 1.7% | 21.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,868.0 Cr | 0.3% | -5.5% | 14.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹176,010.0 Cr | 0.3% | 7.9% | 53.5% | Stock Analytics | |
CIPLA | ₹120,318.0 Cr | 1.7% | -1.3% | 1.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,644.0 Cr | 3.1% | 11.2% | 8.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹106,406.0 Cr | -1% | -4.4% | 16.3% | Stock Analytics |
IPCA LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
IPCA LABORATORIES | -2.6% |
1.7% |
21.3% |
SENSEX | -0.2% |
1% |
10.2% |
You may also like the below Video Courses